跳至主要内容
临床试验/NCT03501693
NCT03501693已完成不适用

A Multi-Reader Multi-Case Controlled Clinical Trial to Evaluate the Comparative Accuracy of the Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study

Fujifilm Medical Systems USA, Inc.1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2018年4月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
Compare Per Subject AUC: DBT Plus S-View Versus FFDM

研究概览

简要总结

The purpose of the pivotal reader study is to assess the comparative accuracy of Fujifilm DBT plus S-View versus FFDM in the detection of breast cancer.

详细描述

This clinical research is a retrospective, pivotal, multi-reader, multi-case (MRMC) study with an enriched sample of 300 breast screening or diagnostic cases which were selected from the library of mammograms collected under Fujifilm protocol FMSU2013-004A (all subjects previously provided written informed consent agreeing their image data and supporting documentation could be used for future research and investigations). Approximately 18 qualified radiologists will independently perform two reads on all (approximately 300) cases. Each reader will read each case both as a FFDM read, and a DBT plus S-View read on the ASPIRE Bellus II workstation.

As its primary endpoint, this study is designed to evaluate whether the area under the receiver operating characteristic (ROC) curve (AUC) based on probability of malignancy (POM) scores and requiring correct lesion localization is statistically non-inferior for DBT plus S-View versus FFDM.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • •Female subjects participating in FMSU2013-004A protocol with known clinical status

排除标准

  • •Female subjects that did not have known clinical status in FMSU2013-004A

结局指标

主要结局

Compare Per Subject AUC: DBT Plus S-View Versus FFDM

时间窗: 4 weeks

Average of each radiologist reader's ROC (receiving operating characteristic curve) based on per-subject POM (probability of malignancy) scores requiring correct lesion localization. A ROC curve is a plot of Sensitivity versus 1-Specificity and is a summary of diagnostic performance of a device or clinician. The reader will first record whether there are mammographic findings and an initial BI-RADS assessment of 0, 1, or 2. If the answer to this question is "no" the reader will be asked to confirm for this case: a BI-RADS assessment category of 1 or 2, a Probability of Malignancy (POM) score following the POM guidance provided in the protocol, and recall decision of "no". If the reader answers "yes" to whether there are mammographic findings, the reader will be asked to confirm an initial BI-RADS assessment category of 0, and will then provide detailed information on each suspicious finding (up to three findings) and the decision whether or not to recall the subject.

次要结局

  • Compare Per-subject Average Recall Rate for All Non-cancer Cases for DBT Plus S-View Versus FFDM(4 weeks)
  • Compare Per-subject Average Recall Rate for DBT Plus S-View Versus FFDM for All Cancer Cases(4 weeks)
  • Compare Per-subject Average Sensitivity for DBT Plus S-View Versus FFDM(Four weeks)

研究者

发起方
Fujifilm Medical Systems USA, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验